Coverart for item
The Resource Assessment of Preclinical Organ Damage in Hypertension

Assessment of Preclinical Organ Damage in Hypertension

Label
Assessment of Preclinical Organ Damage in Hypertension
Title
Assessment of Preclinical Organ Damage in Hypertension
Creator
Contributor
Subject
Language
eng
Summary
This book presents up-to-date information on how to assess early preclinical alterations in the heart, the small and large arteries and the kidney using the most sensitive, specific and cost-effective techniques. A wide variety of techniques are discussed, with careful attention to the latest developments. For each organ, evidence is documented regarding the prevalence of organ damage in the general and the hypertensive population. Information is provided on the potential induction of regression of organ damage by treatment, the criteria for establishing significant changes and the clinical prognostic significance of regression. The manual will be invaluable for all practitioners responsible for the clinical management of hypertensive patients, given that the assessment of early preclinical cardiovascular and renal damage permits more accurate risk stratification at baseline and facilitates evaluation of cardiovascular protection when regression of structural changes is achieved during treatment
Cataloging source
MiAaPQ
Literary form
non fiction
Nature of contents
dictionaries
Assessment of Preclinical Organ Damage in Hypertension
Label
Assessment of Preclinical Organ Damage in Hypertension
Link
http://libproxy.rpi.edu/login?url=https://ebookcentral.proquest.com/lib/rpi/detail.action?docID=2094406
Publication
Copyright
Related Contributor
Related Location
Related Agents
Related Authorities
Related Subjects
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Foreword -- Contents -- Part I: Heart -- 1: Evaluation of Cardiac Damage in Hypertension: Electrocardiography -- 1.1 Pathophysiology of Cardiac Target-Organ Damage -- 1.2 The Electrocardiogram -- 1.3 Electrocardiographic Left Ventricular Hypertrophy -- 1.4 Electrocardiographic ST/T Abnormalities -- 1.5 QRS Duration -- 1.6 Atrial Fibrillation -- 1.7 Electrocardiography vs. Echocardiography and Magnetic Resonance Imaging -- References -- 2: Evaluation of Cardiac Damage in Hypertension: Echocardiography -- 2.1 How to Assess -- 2.1.1 Cardiac Structure -- 2.1.2 LV Diastolic Function -- 2.1.3 LV Systolic Function -- 2.1.4 Aortic Root -- 2.2 Prevalence -- 2.3 Change with Treatment -- 2.4 Prognostic Value of Change -- References -- 3: Modern Diagnostic Approach for the Assessment of Cardiac Damage in Hypertension: 3D, CT and MRI -- 3.1 Three-Dimensional Echocardiography in Hypertension -- 3.1.1 Left Ventricular Systolic Function -- 3.1.2 Assessment of Left Ventricular Mass -- 3.1.3 Contrast-Enhanced Real-Time 3D Echocardiography -- 3.1.4 3D Speckle Tracking -- 3.1.5 Diastolic Function -- 3.1.6 Assessment of Left Atrial Structure and Function -- 3.2 Cardiac Computed Tomography in Hypertension -- 3.3 Magnetic Resonance in Hypertension -- References -- Part II: Large Arteries -- 4: Ultrasound: Carotid Intima-Media Thickness and Plaque (2D-3D) -- 4.1 How to Assess -- 4.2 Prevalence -- 4.3 Change with Treatment (Criteria for Significant Change, Incidence During Treatment) -- 4.4 Prognostic Value of Baseline and of Changes of IMT and Plaque -- Conclusions -- References -- 5: Echocardiographic Assessment of the Aorta and Coronary Arteries in Hypertensive Patients -- 5.1 Aorta -- 5.1.1 How to Assess -- 5.1.1.1 Transthoracic Echocardiographic -- 5.1.1.2 Transesophageal Echocardiography -- 5.1.1.3 Measurement of Aorta Dimensions
  • 5.1.1.4 Aortic Pressure-Dimension Relationship -- 5.1.2 The Aorta and Blood Pressure -- 5.1.3 Relationship Between 24-h Ambulatory Blood Pressure and Aortic Dimensions -- 5.1.4 Modifications of the Aorta and Cardiovascular Events -- 5.2 Coronary Arteries -- 5.2.1 Coronary Artery Remodeling in Hypertension -- 5.2.2 Methods for Assessment -- 5.2.3 Coronary Circulation: Functional Changes -- 5.2.4 How to Perform Coronary Flow Reserve Measurements -- 5.2.4.1 Invasive -- 5.2.4.2 Noninvasive -- 5.2.4.3 Changes of CFR in Hypertension -- 5.2.4.4 Clinical Perspectives -- References -- 6: Pulse Wave Velocity and Central Blood Pressure -- 6.1 Introduction -- 6.2 How to Assess Arterial Stiffness and Central Blood Pressure -- 6.2.1 How to Assess Arterial Stiffness -- 6.2.1.1 Regional Measurements of Arterial Stiffness -- 6.2.1.2 Local Determination of Arterial Stiffness -- 6.2.1.3 Systemic Arterial Stiffness -- 6.2.2 How to Assess Central Blood Pressure -- 6.3 Prevalence -- 6.3.1 Normal and Reference Values of Pulse Wave Velocity -- 6.3.2 Normal and Reference Values of Central Blood Pressure -- 6.4 Changes with Treatment -- 6.4.1 Changes in Pulse Wave Velocity with Antihypertensive Drugs -- 6.4.2 Drugs and BP-Independent Destiffening of Large Artery -- 6.4.3 Change in Central Blood Pressure with Antihypertensive Drugs -- 6.5 Prognostic Value of Change -- 6.5.1 Prognostic Value of the Changes in Pulse Wave Velocity -- 6.5.2 Prognostic Value of the Changes in Central Blood Pressure -- Conclusion -- References -- 7: Ankle-Brachial Index (ABI) -- 7.1 Introduction -- 7.2 How to Assess Ankle Blood Pressure and Calculating the Ankle-Brachial Index? -- 7.3 Epidemiology -- 7.4 Changes of Ankle Pressure and of ABI with Treatment -- 7.5 Prognostic Value of ABI -- Conclusions -- References
  • 8: Atherosclerosis and General Principles of Arterial Imaging -- 8.1 Early Stages of Atherosclerosis -- 8.2 Later Stages of Atherosclerosis -- 8.3 How Can the Characteristics of the Vulnerable Plaques Be Assessed? -- 8.3.1 Intravascular Ultrasound (IVUS), Optical Coherence Tomography (OCT) and Near-Infrared Spectroscopy (NIRS) -- 8.3.2 Ultrasound -- 8.3.2.1 Effects of Drug Interventions -- 8.3.3 Computed Tomography (CT) -- 8.3.4 Magnetic Resonance (MR) -- 8.3.5 Hybrid Techniques -- References -- 9: Imaging and Ageing of the Aorta and Large Arteries in the Lower Extremity -- 9.1 Introduction -- 9.2 Plain X-Ray -- 9.3 Ultrasound -- 9.4 Intravascular Ultrasound (IVUS) -- 9.5 Computer Tomography (CT) -- 9.6 Preoperative Imaging -- 9.7 Postoperative Imaging -- 9.8 Magnetic Resonance Imaging (MR) -- 9.9 Digital Subtraction Angiography (DSA) -- 9.10 Rotation Angiography, Cone Beam CT and Fusion -- 9.11 Integrated Positron Emission Tomography and Computed Tomography (PET-CT) or Magnetic (MR-PET) -- 9.12 Ageing of Arteries: The Role of Arterial Stiffness -- References -- Part III: Small Arteries -- 10: Micromyography -- 10.1 Introduction -- 10.2 Methods of Evaluation of Vascular Structural Alterations -- 10.3 Vascular Structural Alterations as Evaluated by Micromyography, Organ Damage and Prognosis -- References -- 11: Damage of Retinal Arterioles in Hypertension -- 11.1 Assessment of the Retinal Arterioles -- 11.1.1 Funduscopy -- 11.1.2 Scanning Laser Doppler Flowmetry -- 11.2 Prevalence and Incidence (General Population, Hypertension) -- 11.2.1 Funduscopy -- 11.2.2 Scanning Laser Doppler Flowmetry -- 11.3 Change with Treatment (Criteria for Significant Change, Incidence During Treatment) -- 11.3.1 Funduscopy -- 11.3.2 Scanning Laser Doppler Flowmetry -- 11.4 Prognostic Value of Change -- 11.4.1 Funduscopy
  • 11.4.2 Scanning Laser Doppler Flowmetry -- References -- 12: Capillaroscopy -- 12.1 How to Perform -- 12.2 Clinical Application of Capillaroscopy -- 12.3 Microvascular Rarefaction in Hypertension -- References -- 13: Other Techniques for the Assessment of Small Artery Damage in Hypertension -- 13.1 Plethysmography -- 13.2 New Techniques of Evaluation of Microcirculation -- Conclusions -- References -- Part IV: Kidney -- 14: Proteinuria-Microalbuminuria in Renal Damage -- 14.1 Introduction -- 14.2 How to Assess -- 14.2.1 Urine Sample -- 14.2.2 Method -- 14.2.3 Definitions -- 14.3 Prevalence -- 14.4 Change with Treatment -- 14.5 Prognostic Value of Change -- Bibliography -- 15: Glomerular Filtration Rate in Renal Damage -- 15.1 Introduction -- 15.2 How to Assess -- 15.2.1 Definitions -- 15.3 Prevalence -- 15.4 Change with Treatment (Criteria for Significant Change, Incidence During Treatment) -- 15.5 Prognostic Value of Change -- References -- 16: Other Methods to Assess Renal Damage -- 16.1 Introduction -- 16.2 Ultrasound and Doppler-Derived Renal Resistive Index -- 16.3 Computed Tomography and Renal Artery Calcium -- 16.4 Functional Magnetic Resonance Imaging -- 16.4.1 Dynamic Contrast-Enhanced MRI -- 16.4.2 Diffusion-Weighted MRI -- 16.4.3 Blood-Oxygen-Level-Dependent MRI -- References -- Part V: Brain -- 17: MRI/CT: Evaluation of Brain Damage in Hypertension -- 17.1 Types of Vascular Brain Injury -- 17.1.1 White Matter Hyperintensity -- 17.1.1.1 Definition -- 17.1.1.2 Epidemiology -- 17.1.1.3 Association with Hypertension -- 17.1.1.4 Prognostic Value -- 17.1.2 Cerebral Microbleeds (MBs) -- 17.1.2.1 Definition -- 17.1.2.2 Epidemiology -- 17.1.2.3 Association with Hypertension -- 17.1.2.4 Prognostic Value -- 17.1.3 Recent Small Subcortical Infarct -- 17.1.3.1 Definition -- 17.1.3.2 Epidemiology
  • 17.1.3.3 Association with Hypertension -- 17.1.3.4 Prognostic Value -- 17.1.4 Lacunes of Presumed Vascular Origin -- 17.1.4.1 Definition -- 17.1.4.2 Epidemiology -- 17.1.4.3 Association with Hypertension -- 17.1.4.4 Prognostic Value -- 17.1.5 Dilated Perivascular Space (dPVS) -- 17.1.5.1 Definition -- 17.1.5.2 Epidemiology -- 17.1.5.3 Association with Hypertension -- 17.1.5.4 Prognostic Value -- 17.1.6 Brain Atrophy -- 17.1.6.1 Definition -- 17.1.6.2 Epidemiology -- 17.1.6.3 Association with Hypertension -- 17.1.6.4 Prognostic Value -- References -- 18: Questionnaires for Cognitive Function Evaluation -- 18.1 Summary -- References -- 19: Other Techniques for Neurological Damage Evaluation -- 19.1 Cerebral Autoregulation and High Blood Pressure -- 19.2 Transcranial Doppler and Cerebral Hemodynamics -- 19.3 Cerebral SPECT -- 19.4 Summary -- References -- Part VI: Relationships Between Target Organ Damage and Blood Pressure Changes -- 20: Organ Damage and Blood Pressure in Untreated and Treated Hypertensives -- 20.1 Introduction -- 20.1.1 BP and Cardiac Damage -- 20.1.1.1 Left Ventricular Hypertrophy (LVH) -- 20.1.1.2 Other Measures of Cardiac Damage -- 20.1.2 BP and Renal Damage -- 20.1.2.1 Microalbuminuria and Proteinuria -- 20.1.2.2 Reduction of Glomerular Filtration Rate -- 20.1.3 BP and Vascular Damage -- 20.1.3.1 Carotid Intima-Media Thickness -- 20.2 Office or Out-of-Office BP? -- 20.3 Organ Damage and BP Phenomena Other than Mean Values -- References
http://library.link/vocab/cover_art
https://contentcafe2.btol.com/ContentCafe/Jacket.aspx?Return=1&Type=S&Value=9783319156033&userID=ebsco-test&password=ebsco-test
Dimensions
unknown
http://library.link/vocab/discovery_link
{'f': 'http://opac.lib.rpi.edu/record=b4383001'}
Extent
1 online resource (214 pages)
Form of item
online
Isbn
9783319156033
Media category
computer
Media MARC source
rdamedia
Media type code
c
Sound
unknown sound
Specific material designation
remote

Library Locations

    • Folsom LibraryBorrow it
      110 8th St, Troy, NY, 12180, US
      42.729766 -73.682577
Processing Feedback ...